Pfizer
PFE
2,392 hedge funds and large institutions have $173B invested in Pfizer in 2019 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 906 increasing their positions, 1,113 reducing their positions, and 111 closing their positions.
19% more first-time investments, than exits
New positions opened: 132 | Existing positions closed: 111
19% more call options, than puts
Call options by funds: $1.53B | Put options by funds: $1.29B
1.62% more ownership
Funds ownership: 75.91% → 77.53% (+1.6%)
0% less funds holding
Funds holding: 2,404 → 2,392 (-12)
4% less capital invested
Capital invested by funds: $180B → $173B (-$6.79B)
19% less repeat investments, than reductions
Existing positions increased: 906 | Existing positions reduced: 1,113
38% less funds holding in top 10
Funds holding in top 10: 328 → 202 (-126)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$967M |
| 2 |
Goldman Sachs
New York
|
+$597M |
| 3 |
D.E. Shaw & Co
New York
|
+$436M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$372M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$287M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$715M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$442M |
| 3 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$440M |
| 4 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$372M |
| 5 |
CSIA
Charles Schwab Investment Advisory
San Francisco,
California
|
-$338M |
PFE Hedge Fund Activity: Q1 2019 in Review
2,392 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2019, worth a combined $173B — down 3.8% from $180B a quarter earlier.
Buyers outnumbered sellers: 132 funds opened new PFE positions and 111 closed out — a net gain of 21 holders — while 906 added to existing stakes and 1,113 trimmed.
The largest buyer was Capital World Investors, adding an estimated $967M. The largest seller was BlackRock, cutting an estimated $715M.
- 2,392 institutional investors held Pfizer (PFE) as of Q1 2019, down from 2,404 in Q4 2018.
- Funds reported $173B of Pfizer stock for Q1 2019, down 3.8% quarter-over-quarter.
- 132 funds opened new Pfizer positions in Q1 2019 and 111 closed out, a net change of +21 holders.
- The largest Pfizer buyer in Q1 2019 was Capital World Investors, an estimated $967M added.
- The largest Pfizer seller in Q1 2019 was BlackRock, an estimated $715M sold.
Based on aggregated 13F filings for Q1 2019.